Literature DB >> 17235515

Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications.

Jane Yip1, Jean-Jacques Soghomonian, Gene J Blatt.   

Abstract

The recent identification of decreased protein levels of glutamate decarboxylase (GAD) 65 and 67 isoforms in the autistic cerebellar tissue raises the possibility that abnormal regulation of GABA production in individual neurons may contribute to the clinical features of autism. Reductions in Purkinje cell number have been widely reported in autism. It is not known whether the GAD changes also occur in Purkinje cells at the level of transcription. Using a novel approach, the present study quantified GAD67 mRNA, the most abundant isoform in Purkinje cells, using in situ hybridization in adult autistic and control cases. The results indicate that GAD67 mRNA level was reduced by 40% in the autistic group (P < 0.0001; two-tailed t test), suggesting that reduced Purkinje cell GABA input to the cerebellar nuclei potentially disrupts cerebellar output to higher association cortices affecting motor and/or cognitive function. These findings may also contribute to the understanding of previous reports of alterations in the GABAergic system in limbic and cerebro-cortical areas contributing to a more widespread pathophysiology in autistic brains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235515     DOI: 10.1007/s00401-006-0176-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  114 in total

1.  Late development of the GABAergic system in the human cerebral cortex and white matter.

Authors:  Gang Xu; Kevin G Broadbelt; Robin L Haynes; Rebecca D Folkerth; Natalia S Borenstein; Richard A Belliveau; Felicia L Trachtenberg; Joseph J Volpe; Hannah C Kinney
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

2.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

Review 3.  Novel approaches to studying the genetic basis of cerebellar development.

Authors:  Samin A Sajan; Kathryn E Waimey; Kathleen J Millen
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 4.  Postoperative cerebellar mutism and autistic spectrum disorder.

Authors:  Erol Tasdemiroğlu; Miktat Kaya; Can Hakan Yildirim; Levent Firat
Journal:  Childs Nerv Syst       Date:  2010-10-30       Impact factor: 1.475

Review 5.  Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.

Authors:  Sanjiv B Amin; Tristram Smith; Hongyue Wang
Journal:  J Autism Dev Disord       Date:  2011-11

Review 6.  Use of transcranial magnetic stimulation in autism spectrum disorders.

Authors:  Lindsay M Oberman; Alexander Rotenberg; Alvaro Pascual-Leone
Journal:  J Autism Dev Disord       Date:  2015-02

7.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

8.  Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism.

Authors:  Anwesha Banerjee; Francisco García-Oscos; Swagata Roychowdhury; Luis C Galindo; Shawn Hall; Michael P Kilgard; Marco Atzori
Journal:  Int J Neuropsychopharmacol       Date:  2012-12-11       Impact factor: 5.176

9.  Targeting Gamma-Related Pathophysiology in Autism Spectrum Disorder Using Transcranial Electrical Stimulation: Opportunities and Challenges.

Authors:  Fae B Kayarian; Ali Jannati; Alexander Rotenberg; Emiliano Santarnecchi
Journal:  Autism Res       Date:  2020-05-28       Impact factor: 5.216

10.  Abnormal morphology and subcortical projections to the medial geniculate in an animal model of autism.

Authors:  Yusra Mansour; Syed Naved Ahmed; Randy Kulesza
Journal:  Exp Brain Res       Date:  2020-11-16       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.